Existing users please login

 

Home / Markets

Market Winners & Losers: American Capital, Celgene

 
     

    It was choppy trading for the markets Tuesday, but the indices weathered the storm and landed in the green with the Standard & Poor's 500 closing up 7.25 points, or 0.78%, at 934.70.

    Here’s a look at some of the session’s winners and losers:

    Winners

    American Capital Ltd. (ACAS)
    Shares of the principal investment firm soared 40.58% today, following the general upswing of the financial sector.

    Developers Diversified Realty Corp. (DDR)
    News that the manager and developer of the shopping-center stands promoted two executives sent the stock jumping 35.96%.

    Ciena Corp. (CIEN)
    An upgrade from an analyst sent shares of the communications equipment maker up 18.64%

    LSI Corp.(LSI)
    Shares of the electronics company increased 18.04% along with others in the tech sector.

    JDS Uniphase Corp.(JDSU)
    The communications equipment company jumped 15.89%.

     

    Losers

    Intercontinental Exchange Inc. (ICE)
    Following the release of the company’s December trading volume data, shares of the global exchange and OTC market operator dropped more than 10%. Last year was a rough one for the company with its stocks dropping 60%.

    Celgene (CELG)
    A downgrade from an analyst citing worries the company won’t meet 2009’s growth expectations sent shares of the biopharmaceutical company falling 7.16% today.

    Laboratory Corp. of America Holdings (LH)
    The provider of clinical laboratory services cut its 2009 earnings and revenue projections saying it now expects to earn $4.75 to $4.95 a share compared to earlier estimates of $5 to $5.25. The gloomy outlook sent the company's stock down 6.49%.

    Coventry Health Care Inc. (CVH)
    After being downgraded by a analyst at Deutsche Securities shares of the health-care company fell 6.25%.

    Quest Diagnostics Inc. (DGX)
    The maker of medical diagnostic tests fell 5.88% after it declared a quarterly cash dividend on Quest Diagnostics common stock of $0.10 per share.